Skip to main content

Table 2 Univariate analysis for breast cancer-specific disease-free survival

From: Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing

Prognostic factor

P

RR

95% CI

Age

n.s.

-

-

Menopausal status

n.s.

-

-

pT stage

n.s.

-

-

Grade

0.0002

3.35

1.77–5.99

Steroid hormone receptor status

n.s.

-

-

HER2_SCO

n.s.

  

HER2_AMP

0.004

3.07

1.44–6.57

HER2_ALG

n.s.

-

-

HER2_COM

0.006

3.27

1.40–7.65

  1. CI, confidence interval; n.s., not significant; RR, relative risk.